https://www.indianpharmapost.com/gland-pharma-receives-usfdas-tentative-approval-for-latanoprostene-bunod-ophthalmic-solution-159112024-07-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-biologicals-receives-registration-approval-for-adalimumab-from-morocco-moh-159122024-07-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-usfdas-final-approval-for-valsartan-tablets-159132024-07-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/thyrocare-technologies-posts-q1-fy25-consolidated-profit-at-rs-2417-cr-159142024-07-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/torrent-pharmaceuticals-posts-q1-fy25-consolidated-pat-at-rs-457-cr-159152024-07-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-receives-usfdas-final-approval-for-fluphenazine-hydrochloride-tablets-159162024-07-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/syngene-reports-drop-in-q1-fy25-revenue-to-rs-790-cr-159172024-07-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-successfully-inspects-carbogen-amciss-manufacturing-sites-in-neuland-and-aarau-159182024-07-24T00:00:00+05:30always0.9